Cargando…

Mechanisms of Cisplatin in Combination with Repurposed Drugs against Human Endometrial Carcinoma Cells

Although endometrial carcinoma is one of the most common gynecological malignancies worldwide, its precise etiology remains unknown. Moreover, no novel adjuvant and/or targeted therapies are currently being developed to achieve greater efficacy for endometrial cancer patients who develop chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chi-Kang, Liu, Shu-Ting, Wu, Zih-Syuan, Wang, Yu-Chi, Huang, Shih-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922822/ https://www.ncbi.nlm.nih.gov/pubmed/33669781 http://dx.doi.org/10.3390/life11020160

Ejemplares similares

Palmitate Enhances the Efficacy of Cisplatin and Doxorubicin against Human Endometrial Carcinoma Cells
por: Wu, Zih-Syuan, et al.
Publicado: (2021)

Mitochondrial Dysfunction Involved in the Cytotoxicity of Tramadol in Human Endometrial Carcinoma Cells
por: Liu, Li-Chun, et al.
Publicado: (2022)

Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide
por: Feng, Shao-Wei, et al.
Publicado: (2023)

An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization
por: Torricelli, Federica, et al.
Publicado: (2023)

Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells
por: Miyamoto, Tsutomu, et al.
Publicado: (2016)

From GWAS to drug screening: repurposing antipsychotics for glioblastoma
por: Lin, Wei-Zhi, et al.
Publicado: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria
por: Liu, Yuan, et al.
Publicado: (2021)

Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
por: Yuan, Mingjun, et al.
Publicado: (2018)

Treatment mechanism of immune triad from the repurposing drug against COVID-19
por: Lee, Jong hoon
Publicado: (2023)

Strategies for drug repurposing against coronavirus targets
por: Smith, Poppy O., et al.
Publicado: (2021)

In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022)

Anti-HIV drug repurposing against SARS-CoV-2
por: Sang, Peng, et al.
Publicado: (2020)

Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin
por: Tseng, Chia-Yi, et al.
Publicado: (2016)

Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans
por: Lin, Jiaying, et al.
Publicado: (2022)

Drug repurposing screens and synergistic drug‐combinations for infectious diseases
por: Zheng, Wei, et al.
Publicado: (2017)

Synergistic drug combinations and machine learning for drug repurposing in chordoma
por: Anderson, Edward, et al.
Publicado: (2020)

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma
por: Regan-Fendt, Kelly, et al.
Publicado: (2020)

Repurposing of gastric cancer drugs against COVID-19
por: Sonkar, Charu, et al.
Publicado: (2021)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Amlodipine and lufenuron as repurposing drugs against Sporothrix brasiliensis
por: Poester, Vanice Rodrigues, et al.
Publicado: (2023)

Therapeutic Effect of Repurposed Temsirolimus in Lung Adenocarcinoma Model
por: Chang, Hsuen-Wen, et al.
Publicado: (2018)

The updated landscape of tumor microenvironment and drug repurposing
por: Jin, Ming-Zhu, et al.
Publicado: (2020)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in Drosophila
por: Wu, Shih-Cheng, et al.
Publicado: (2017)

Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinoma
por: Lerario, Antonio M., et al.
Publicado: (2018)

Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19
por: Bibi, Nousheen, et al.
Publicado: (2020)

Hyaluronan–cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin/alginate microbeads for colon drug delivery
por: Tsai, Shiao-Wen, et al.
Publicado: (2013)

Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells
por: Lin, Chi-Kang, et al.
Publicado: (2019)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Novel Treatments against Mycobacterium tuberculosis Based on Drug Repurposing
por: Mourenza, Álvaro, et al.
Publicado: (2020)

Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

Memantine hydrochloride: a drug to be repurposed against Chikungunya virus?
por: Pereira, Anna Karla dos Santos, et al.
Publicado: (2021)

Advances in the computational landscape for repurposed drugs against COVID-19
por: Aronskyy, Illya, et al.
Publicado: (2021)

Repurposing drugs with specific activity against L-form bacteria
por: Emami, Kaveh, et al.
Publicado: (2023)

Repurposing of drugs against methyltransferase as potential Zika virus therapies
por: Shukla, Rohit, et al.
Publicado: (2023)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022)

Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders
por: Lee, Hyeong-Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_271120o0s353f3p985k3jrupue